160
Participants
Start Date
June 30, 2007
Primary Completion Date
September 30, 2010
Study Completion Date
November 30, 2012
Gemcitabine
Gemcitabine will be administered 1000 mg/m2 pm Days 1 and 8 of a 21 day cycle
Sorafenib
Sorafenib will be administered (400 mg; 2 tablets x 200 mg) orally twice daily (approximately every 12 hours)
Placebo
Placebo will be administered (400 mg; 2 tablets x 200 mg) orally twice daily (approximately every 12 hours)
Capecitabine
Capecitabine will be administered orally at a dose of 1,000 mg/m2 twice daily, within 30 minutes after a meal, for 14 days followed by a 7 day rest period (without capecitabine).
Memorial Sloan-Kettering Cancer Center, New York
Queens Cancer Center, Jamaica
Hematology Oncology Associates of New York, East Syracuse
Roswell Park Cancer Institute, Buffalo
Hematology Oncology of Northeast Pennsylvania, Dunmore
Pennsylvania Oncology Hematology Associates, Philadelphia
Georgetown University Medical Center, Washington D.C.
Washington Cancer Institute, Washington D.C.
Presbyterian Hospital, Charlotte
Charleston Hematology Oncology Associates, Charleston
Northwest Georgia Oncology Center, Marietta
Augusta Oncology Associates, PC, Augusta
Cascade Cancer Center, Macon
Central Georgia Cancer Care, Macon
Pasco Hernando Oncology Associates PA, Brooksville
Pasco Hernando Oncology Associates PA, New Port Richey
The West Clinic, Memphis
North Coast Cancer Care, Sandusky
Northern Indiana Cancer Research Consortium, South Bend
University of Michigan Comprehensive Cancer Center, Ann Arbor
Oncology Alliance, Glendale
Ingalls Memorial Hospital, Harvey
Northwestern University-Robert H. Lurie Comprehensive Cancer Center, Chicago
Rush University Medical Center, Chicago
Quincy Medical Group, Quincy
Columbia Comprehensive Cancer Care Clinic & Research Institute, Jefferson City
Mary Bird Perkins Cancer Center, Baton Rouge
Highlands Oncology Group, Fayetteville
Front Range Cancer Specialists, Fort Collins
Long Beach Memorial Medical Center, Long Beach
Compassionate Cancer Care-Riverside, Riverside
Compassionate Cancer Care-Corona, Corona
Compassionate Cancer Care-Fountain Valley, Fountain Valley
California Pacific Medical Center, San Francisco
University of California San Francisco Comprehensive Cancer Center, San Francisco
Sutter Cancer Center, Sacramento
Providence Cancer Center / Katmai Oncology Group LLC, Anchorage
California Cancer Care, Greenbrae
Hematology Oncology PC / Bennett Cancer Center, Stamford
Oncology Associates of Bridgeport, Trumbull
Maine Center for Cancer Medicine, Scarborough
Boston Medical Center, Boston
Baystate Medical Center, Springfield
Oncology Hematology Specialists, PA, Denville
Collaborators (1)
Amgen
INDUSTRY
Accelerated Community Oncology Research Network
OTHER